Hepatitis B vaccine immunogenicity among adults vaccinated during an outbreak response in an assisted living facility-Virginia, 2010

Vaccine

Volumn 32, Issue 7, 2014, Pages 852-856

  Bender, Thomas John ^a   Sharapov, Umid ^a   Utah, Okey ^b   Xing, Jian ^a   Hu, Dale ^a   Rybczynska, Jolanta ^a   Drobeniuc, Jan ^a   Kamili, Saleem ^a   Spradling, Philip R ^a   Moorman, Anne C ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b VIRGINIA DEPARTMENT OF HEALTH   (United States)

Author keywords

Age; HBV; Hepatitis B; Neuropsychiatric; Vaccination

Indexed keywords

HEPATITIS A HEPATITIS B VACCINE; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; ASSISTED LIVING FACILITY; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEPATITIS A; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOGENICITY; KIDNEY DISEASE; LIVER DISEASE; MALE; MIDDLE AGED; PRIORITY JOURNAL; RACE DIFFERENCE; SINGLE DRUG DOSE; SMOKING; TREATMENT DURATION; UNITED STATES; VIRUS TRANSMISSION;

AGE; HBV; HEPATITIS B; NEUROPSYCHIATRIC; VACCINATION;

ADULT; AGED; AGED, 80 AND OVER; ASSISTED LIVING FACILITIES; DISEASE OUTBREAKS; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; MALE; MIDDLE AGED; VACCINATION; VIRGINIA;

EID: 84892849102     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.12.018     Document Type: Article

References (33)

1. Centers for Disease Control and Prevention National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011 2011, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA.
2. Louie R.F., Lau M.J., Lee J.H., Tang Z., Kost G.J. Multicenter study of the prevalence of blood contamination on point-of-care glucose meters and recommendations for controlling contamination. Point Care 2005, 4:158-163.
3. Thompson N.D., Perz J.F., Moorman A.C., Holmberg S.D. Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998-2008. Ann Intern Med 2009, 150:33-39.
4. Centers for Disease Control and Prevention Transmission of hepatitis B virus among persons undergoing blood glucose monitoring in long-term-care facilities-Mississippi, North Carolina, and Los Angeles County, California, 2003-2004. MMWR Morb Mortal Wkly Rep 2005, 54:220-223.
5. Centers for Disease Control and Prevention Notes from the field: deaths from acute hepatitis B virus infection associated with assisted blood glucose monitoring in an assisted-living facility-North Carolina, August-October 2010. MMWR Morb Mortal Wkly Rep 2011, 60:182.
6. Quale J.M., Landman D., Wallace B., Atwood E., Ditore V., Fruchter G. Deja vu: nosocomial hepatitis B virus transmission and fingerstick monitoring. Am J Med 1998, 105:296-301.
7. Centers for Disease Control and Prevention Nosocomial hepatitis B virus infection associated with reusable fingerstick blood sampling devices-Ohio and New York City, 1996. MMWR Morb Mortal Wkly Rep 1997, 46:217-221.
8. Polish L.B., Shapiro C.N., Bauer F., Klotz P., Ginier P., Roberto R.R., et al. Nosocomial transmission of hepatitis B virus associated with the use of a spring-loaded finger-stick device. N Engl J Med 1992, 326:721-725.
9. Centers for Disease Control and Prevention Nosocomial transmission of hepatitis B virus associated with a spring-loaded fingerstick device-California. MMWR Morb Mortal Wkly Rep 1990, 39:610-613.
10. Food and Drug Administration Safety alert: hepatitis B transmission via spring-loaded lancet devices 1990, Department of Health and Human Services, US Public Health Service, Food and Drug Administration, Rockville, MD.
11. Centers for Disease Control and Prevention Multiple outbreaks of hepatitis B virus infection related to assisted monitoring of blood glucose among residents of assisted living facilities-Virginia, 2009-2011. MMWR Morb Mortal Wkly Rep 2012, 61(19):339-343.
12. Centers for Disease Control and Prevention Notes from the field-ongoing transmission of HBV among ALF residents despite ongoing public health efforts, Virginia 2012. Morbid Mortal Weekly Rep 2013, 62(19):389.
13. Bender T.J., Wise M.E., Utah O., Xing J., Moorman A.C., Sharapov U.M., et al. Outbreak of hepatitis B virus infections associated with assisted monitoring of blood glucose in an assisted living facility-Virginia, 2010. PLoS One 2012, 7(12):e50012.
14. Centers for Disease Control and Prevention. Healthcare-associated hepatitis B and C outbreaks reported to the Centers for Disease Control and Prevention (CDC) in 2008-2012. [accessed 08.08.13]. http://www.cdc.gov/hepatitis/Statistics/HealthcareOutbreakTable.htm.
15. Counard C.A., Perz J.F., Linchangco P.C., Christiansen D., Ganova-Raeva L., Xia G., et al. Acute hepatitis B outbreaks related to fingerstick blood glucose monitoring in two assisted living facilities. J Am Geriatr Soc 2010, 58:306-311.
16. Sawyer M.H., Hoerger T.A., Murphy T.V., Schillie S.F., Hu D., Spradling P.R., et al. Use of hepatitis B vaccination for adults with diabetes mellitus: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2011, 60:1709-1711.
17. Mast E.E., Weinbaum C.M., Fiore A.E., Alter M.J., Bell B.P., Finelli L., et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 2006, 55:1-33. quiz CE1-4.
18. Pirl W.F., Greer J.A., Weissgarber C., Liverant G., Safren S.A. Screening for infectious diseases among patients in a state psychiatric hospital. Psychiatr Serv 2005, 56:1614-1616.
19. Brunette M.F., Drake R.E., Marsh B.J., Torrey W.C., Rosenberg S.D. Responding to blood-borne infections among persons with severe mental illness. Psychiatr Serv 2003, 54:860-865.
20. Essock S.M., Dowden S., Constantine N.T., Katz L., Swartz M.S., Meador K.G., et al. Risk factors for HIV, hepatitis B, and hepatitis C among persons with severe mental illness. Psychiatr Serv 2003, 54:836-841.
21. Rosenberg S.D., Swanson J.W., Wolford G.L., Osher F.C., Swartz M.S., Essock S.M., et al. The five-site health and risk study of blood-borne infections among persons with severe mental illness. Psychiatr Serv 2003, 54:827-835.
22. Rosenberg S.D., Goodman L.A., Osher F.C., Swartz M.S., Essock S.M., Butterfield M.I., et al. Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health 2001, 91:31-37.
23. Wolters B., Junge U., Dziuba S., Roggendorf M. Immunogenicity of combined hepatitis A and B vaccine in elderly persons. Vaccine 2003, 21:3623-3628.
24. Van der Wielen M., Van Damme P., Chlibek R., Smetana J., von Sonnenburg F. Hepatitis A/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors. Vaccine 2006, 24:5509-5515.
25. Stoffel M., Lievens M., Dieussaert I., Martin I., Andre F. Immunogenicity of Twinrix in older adults: a critical analysis. Expert Rev Vaccines 2003, 2:9-14.
26. Rendi-Wagner P., Kundi M., Stemberger H., Wiedermann G., Holzmann H., Hofer M., et al. Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience. Vaccine 2001, 19:2055-2060.
27. Denis F., Mounier M., Hessel L., Michel J.P., Gualde N., Dubois F., et al. Hepatitis-B vaccination in the elderly. J Infect Dis 1984, 149:1019.
28. Averhoff F., Mahoney F., Coleman P., Schatz G., Hurwitz E., Margolis H. Immunogenicity of hepatitis B Vaccines Implications for persons at occupational risk of hepatitis B virus infection. Am J Prev Med 1998, 15:1-8.
29. Williams R.E., Sena A.C., Moorman A.C., Moore Z.S., Sharapov U.M., Drobenuic J., et al. Hepatitis B vaccination of susceptible elderly residents of long term care facilities during a hepatitis B outbreak. Vaccine 2012, 30:3147-3150.
30. Tohme R.A., Awosika-Olumo D., Nielsen C., Khuwaja S., Scott J., Xing J., et al. Evaluation of hepatitis B vaccine immunogenicity among older adults during an outbreak response in assisted living facilities. Vaccine 2011, 29:9316-9320.
31. Van der Wielen M. Department of Health and Human Services, Centers for Disease Control and Prevention, Advisory Committee on Immunization Practices (ACIP) Summary Report, June 23-24, 2010, page 89 [unpublished data]. [accessed 05.09.13]. http://www.cdc.gov/vaccines/acip/meetings/downloads/min-archive/min-jun10.pdf.
32. Jasjua S., Thompson N.D., Peters P.J., Khudyakov Y.E., Patel M.T., Linchangco P., et al. Investigation of hepatitis B virus and human immunodeficiency virus transmission among severely mentally ill residents at a long term care facility. PLoS One 2012, 7(8):e43252.
33. Wise M.E., Marquez P., Sharapov U., Hathaway S., Katz K., Tolan S., et al. Outbreak of acute hepatitis B virus infections associated with podiatric care at a psychiatric long-term care facility. Am J Infect Control 2012, 40(1):16-21.